| Product NDC: | 66689-028 |
| Proprietary Name: | Levetiracetam |
| Non Proprietary Name: | Levetiracetam |
| Active Ingredient(s): | 100 mg/mL & nbsp; Levetiracetam |
| Administration Route(s): | ORAL |
| Dosage Form(s): | SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 66689-028 |
| Labeler Name: | VistaPharm, Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA078976 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20100125 |
| Package NDC: | 66689-028-50 |
| Package Description: | 5 TRAY in 1 CASE (66689-028-50) > 10 CUP, UNIT-DOSE in 1 TRAY > 5 mL in 1 CUP, UNIT-DOSE (66689-028-01) |
| NDC Code | 66689-028-50 |
| Proprietary Name | Levetiracetam |
| Package Description | 5 TRAY in 1 CASE (66689-028-50) > 10 CUP, UNIT-DOSE in 1 TRAY > 5 mL in 1 CUP, UNIT-DOSE (66689-028-01) |
| Product NDC | 66689-028 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Levetiracetam |
| Dosage Form Name | SOLUTION |
| Route Name | ORAL |
| Start Marketing Date | 20100125 |
| Marketing Category Name | ANDA |
| Labeler Name | VistaPharm, Inc |
| Substance Name | LEVETIRACETAM |
| Strength Number | 100 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE] |